Lenvenib 4mg

Lenvenib 4mg Capsule contains the active ingredient Lenvatinib. This medication is a tyrosine kinase inhibitor used for progressive or advanced thyroid cancer when radioactive iodine therapy is ineffective. Additionally, it is prescribed for liver cancer patients who have not received prior treatment and are not candidates for surgical intervention. Anaplastic Thyroid Carcinoma, a form of advanced thyroid cancer, typically affects individuals over 60 years old. Symptoms include an enlarged, hard thyroid gland and voice hoarseness resulting from nerve paralysis in the larynx. Hepatocellular carcinoma, or liver cancer, often arises from existing liver issues such as cirrhosis or chronic hepatitis B infection. Individuals with a history of allergic reactions to Lenvenib 4mg Capsule or any of its ingredients should avoid this medication. It is important for patients to notify their dentist or oral surgeon about their use of Lenvenib 4mg Capsule, as it may hinder wound healing and elevate bleeding risks. The price of Lenvenib 4mg varies by retailer and location. Alternatives to Lenvenib 4mg include Lenvima, Cabometyx, Nexavar, and Stivarga, depending on the cancer treatment prescribed.